Several studies suggest that pro-inflammatory interleukins such as IL-2 and IL-12 play an important role in the activation and targeting of cytotoxic T lymphocytes and other immune cells to the tumour microenvironment [32,33]. The gene discussed is IL2; the disease is neoplasm.